4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Coya Therapeutics, Inc. (COYA) operates in the Biotechnology industry and is headquartered in Houston, United States with about 8 employees. Its market capitalization is roughly $114 million. In the fiscal year ended 2025-12-31, COYA reported $8M in revenue and ($21M) in net income.
Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary therapies to enhance the function of regulatory T cells (Tregs).
Interactive charts & full statements → Open the COYA valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $8M | $4M | $6M | $0M | — |
| Operating Income (EBIT) | ($23M) | ($17M) | ($8M) | ($10M) | — |
| Net Income | ($21M) | ($15M) | ($8M) | ($12M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $4M | $4M | $0M | $0M |
| Operating Income (EBIT) | ($8M) | ($6M) | ($2M) | ($6M) | ($8M) |
| Net Income | ($7M) | ($6M) | ($2M) | ($6M) | ($7M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $50M | $44M | $41M | $8M | — |
| Total Liabilities | $7M | $5M | $6M | $17M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive COYA viewer.
About TickerBase · Data methodology & sources